HLA-B27 is a class I surface antigen strongly associated with seronegative spondyloarthropathies, such as ankylosing spondylitis. Ankylosing spondylitis is a type of arthritis characterised by long-term inflammation of the joints of the spine. 90% of patients diagnosed with Ankylosing spondylitis (AS) test positive for HLA-B27, thus genotyping is suitable for the differential diagnosis of AS. However, only 1-2% of those who test positive for HLA-B27 develop AS. Therefore, the test is not indicated as a screening test.
HLA-B27 has a frequency of approximately 8% in the general Caucasian population.
Preparation of patient: There is no physical preparation for the HLA-B27 test.
Precautions: None.